Chivalrous
发表于 2025-3-25 05:45:46
http://reply.papertrans.cn/67/6687/668632/668632_21.png
Discrete
发表于 2025-3-25 09:03:30
http://reply.papertrans.cn/67/6687/668632/668632_22.png
掺和
发表于 2025-3-25 15:19:14
Novel Positron-Emitting Radiopharmaceuticalsto provide a bird’s-eye view of the current landscape of emergent PET radiopharmaceuticals, specifically those that have been the subject of multiple clinical trials but have yet to be approved by regulatory agencies for routine use. We will begin with a brief discussion of the fundamental anatomy o
expire
发表于 2025-3-25 19:02:21
http://reply.papertrans.cn/67/6687/668632/668632_24.png
Itinerant
发表于 2025-3-25 21:38:24
Instrumentation for Positron Emission Tomographynners. Although now a mature technology, PET has undergone, and continues to undergo, steady advances in hardware and software and, as a result, ongoing improvements in performance and functionality. Recent noteworthy advances include improvements in detector technology and image reconstruction, imp
metropolitan
发表于 2025-3-26 03:01:58
http://reply.papertrans.cn/67/6687/668632/668632_26.png
STELL
发表于 2025-3-26 07:02:19
http://reply.papertrans.cn/67/6687/668632/668632_27.png
Outmoded
发表于 2025-3-26 12:31:28
http://reply.papertrans.cn/67/6687/668632/668632_28.png
Indolent
发表于 2025-3-26 12:51:23
http://reply.papertrans.cn/67/6687/668632/668632_29.png
Corroborate
发表于 2025-3-26 18:51:12
Diagnostic Applications of Nuclear Medicine: Leukemiasvia the bloodstream. In 2016, the estimated number of new leukemia cases was more than 110,000 in all of Europe and 47,000 in the USA. Leukemia is the cause of 4% of all cancer deaths and accounts for 3.6% of all cancers. Historically, leukemias have been divided into four major categories further c